The update comes after Prime Minister Boris Johnson confirmed he would set out a lockdown exit strategy on Sunday.

Hydroponic systems for edible indoor gardens.

The squabbling over an empty federal seat shows why the National Party remains a problem for Scott Morrison as he plots his post-coronavirus agenda, writes Laura Tingle.

The Million Dollar Fish competition was designed to lure fishermen to the Northern Territory. But a consultant's report obtained by the ABC shows registrations have fallen by half in five years.

Westpac joins ANZ in deferring its interim dividend as it braces for the financial impact of COVID-19, but mounting issues around money laundering and tax reporting may cost it almost as much.

Bombardier Inc. said it has started the gradual resumption of manufacturing operations at both its aircraft and rail operations that had been closed due to the COVID-19 pandemic, as it reported a loss of $200 million US in its first quarter.

General Motors says it plans to restart some production at its engine plant in St. Catharines, Ont. next week ahead of a wider restart of North American operations the week of May 18.

Canada Mortgage and Housing Corp. says construction of multi-unit housing projects remained strong in some provinces last month despite the fight against the COVID-19 pandemic.

Chicago's final frost date usually arrives in mid-May, meaning gardeners can start planting some of their hardier vegetables and seedlings.

A date of June 12 has been put forward as a suggestion for when fixtures can resume, but there are still a number of factors yet to be resolved before football can return

In February 2019, CB Insights announced their third annual AI 100 - a list of the 100 most promising AI startups across the globe. And today, they're recapping where those companies made it in the past 12 months.

Keep on reading: AI Startups of 2019: Where Are They Now?

Subscription focused, The Athletic has grown rapidly since its start in 2016. Founded by Adam Hansmann and Alex Mather, the VC-backed sports website, has bucked the trend by focusing on annual subscriptions. And with its latest funding of $50 million, the company is now worth $500 million.

Keep on reading: Sports writing startup hits $500M valuation

The National Venture Capital Association (NVCA) is closely monitoring the outbreak of the coronavirus (COVID-19) and is working diligently to address the VC industry’s needs and provide resources that aim to help firms and portfolio companies during this challenging time. This webpage provides important information and resources to venture-backed companies about the federal response to COVID-19, including tax credits, loan opportunities, and sick leave. NVCA will update this information as it becomes available.

Keep on reading: Coronavirus Information and Resources for VCs and Startups

The AFL reduces the men's competition to 17 rounds as it responds to the coronavirus pandemic, but it is yet to decide whether it will postpone the start of the season.

Rugby league's governing body says a letter sent by NSW Police Commissioner Mick Fuller shows there is nothing to "preclude the commencement of the modified NRL competition" in May, despite health authorities being wary about relaxing restrictions too soon.

The NRL is leading the charge to get sport restarted, planning games by late next month — but Australia's Federal Sports Minister is urging all codes to have patience amid the coronavirus pandemic.

Cycling's most famous event may still go ahead this year, despite the French Government banning mass gatherings in the country until at least the middle of July.

The NRL is committed to resuming the premiership season on May 28, but the New Zealand-based Warriors claim they have been left in the dark about the league's plans for their move back to Australia.

Annastacia Palaszczuk softens her stance on the NRL's attempt to restart the competition during the coronavirus pandemic, but says the league is yet to submit any plan.

Gillon McLachlan and Peter V'landys may be in charge of two rival football codes, but it would be wise for them to work together to make sure both their games get back on the field this year, writes Richard Hinds.

The SANFL sidesteps speculation it could resume games earlier than planned, despite South Australia recording zero new cases of coronavirus over three consecutive days.

A plan being hatched inside the walls of rugby league headquarters could see Mudgee host games in a modified NRL competition.

NRL clubs will be able to resume training from May 4 as the competition charges towards its planned restart three weeks later.

NRL television broadcasters Channel Nine and Foxtel agree to recognise May 28 as the competition recommencement date following extensive meetings, according to chairman Peter V'landys.

Flattering comparisons with other leading sports officials have also helped elevate the ARL chairman's current status as the can-do man of Australian sport, but as Richard Hinds asks, is he about to make a huge mistake?

Federal Minister Richard Colbeck says he hopes sport halted by the coronavirus pandemic can get started again, but warns NRL players' misbehaviour threatens a return of play.

The resumption of the NRL season on May 28 remains in doubt, with the players seeking answers over pay and other conditions only days out from their planned return to training.

AFL chief Gillon McLachlan is cautiously optimistic following yesterday's National Cabinet meeting — and he leaves open the possibility that the league's hubs model might not be needed to get through the season.

The NRL ticks another box ahead of its planned restart later this month, as the players officially sign off on a new pay agreement ahead of a return to training this week.

Rapman moves from YouTube to feature films with "Blue Story," a tale of two South-East London friends living in different neighborhoods torn apart by gang violence.

uBiome, a San Francisco startup that sells commercial tests that use DNA sequencing to identify what microbes are in a person's stool or, for one test, in the vagina, has raised $83 million from venture capitalists to fund an entrée into drug development.

Employee safety and business continuity are top priorities / Wide-ranging humanitarian and social engagement / Group sales increase by 6.0 percent (Fx & portfolio adj.) to 12.845 billion euros / EBITDA before special items up by 10.2 percent to 4.391 billion euros / All divisions report higher sales and earnings – strong demand at Consumer Health / Net income advances by 20.0 percent to 1.489 billion euros / Core earnings per share increase by 9.9 percent to 2.67 euros / Outlook for 2020: impact of COVID-19 not yet reliably quantifiable

The South Korean Ministry of Food and Drug Safety have approved a local trial to evaluate nafamostat’s effectiveness in COVID-19 patients.

New crop of data suggests drug can speed recovery from COVID-19

It is hoped that the drug may prevent COVID-19

Germany’s science and technology company Merck KGaA today announced its investment in SynSense (formerly…

A settlement with El Dorado County, Calif., will ensure the beginning of the cleanup, at an estimated cost of approximately $7 million, of the Meyers Landfill Site, located outside of the city of South Lake Tahoe, Calif.

Biotech is in the midst of an incredible era of innovation: new modalities and novel medicines delivering real value to patients, leading to a decade-long bull cycle. It’s been exhilarating to watch and participate in this market, and venture capital

The post Wither New Biotech Startups? appeared first on LifeSciVC.

A doctor, researcher and former chronic migraine sufferer, has launched her own biotech startup company named KetoSwiss selling supplements that she argues can help control migraine pain by tapping into our own biological mechanisms.

French beauty supplement firm D+ For Care has launched a mouth spray to aid sleep and has a flurry of holistic wellbeing innovation primed for 2020 â the year nutricosmetics could really take off, its founder says.

On Friday, 21 emerging medical device companies will present their technologies and business plans to a group of local investors at the annual MedTech Showcase, hosted by the Massachusetts Medical Device Industry Council. More than 300 venture leaders and business leaders are expected to attend the event tomorrow, Oct. 28 from 8 a.m. to 2 p.m. at the Westin Waltham, 70 Third Ave. As a main event, John McDonough, president and CEO of Lexington-based T2 Biosystems (Nasdaq: TTOO), will be interviewed…

March 23, 2020 – As the United States grapples with the COVID-19 outbreak and its ongoing fallout, there is another pressing issue that is crucial to the American public: ensuring safe and fair elections between now and Nov. 3. “The Coalition believes it is important for all Americans to be active in the political process […]

The European Medicines Agency has begun a rolling review of data on Gilead’s remdesivir, positioning it to cut the time it takes to decide whether to approve the drug in COVID-19 patients.

Moderna is finalizing the protocol for a phase 3 trial of its COVID-19 vaccine with a view to starting the study early in the summer. The establishment of the timeline, which follows FDA clearance to run a phase 2 trial, puts Moderna on track to win approval for its mRNA vaccine mRNA-1273 next year.